The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1284 participants.

Also called NCT01106677

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,284 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01106677
Other papers using this trial's data
  • Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial Diabetologia, 2013-12 DOI, PubMed 24026211, PMC3825495 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Bulgaria, Colombia, Czechia, Estonia, Greece, India, Latvia, Malaysia, Mexico, Peru, Poland, Portugal, Puerto Rico, Russia, Singapore, Slovakia, Sweden, Thailand, Türkiye, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01106677. Randomized; triple masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-10 (actual). Results posted on 2013-07-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Placebo
Intervention (Drug)
Canagliflozin
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Metformin immediate release
Lead sponsor
Janssen Research & Development, LLC (class: industry)

Record details

Record id
cardio:ct-nct01106677
Content hash
bf9fcdc768a802c67f2b4996673d2e2333f29290bd1b705ed5aa5e49763e27af